Escitalopram Effective for Depression in American Males with Parkinson’s: Case-Control Study
Reading Time: 2 minutes Introduction Parkinson's disease, a neurodegenerative disorder, often coexists with depression, significantly impacting the quality of life of affected individuals. In the United States, where the prevalence of Parkinson's is notable, managing its psychiatric comorbidities is crucial. This article delves into a recent case-control study that investigated the effectiveness of escitalopram, a selective serotonin reuptake inhibitor (SSRI), in managing depression among American males diagnosed with Parkinson's disease. The findings suggest a promising role for escitalopram in improving depressive symptoms, offering hope for better mental health management in this population. Study Design and Methodology The study adopted a case-control approach, comparing outcomes...


